Skip to main content
Caplight Logo









AUSTRAL Dx

AUSTRAL Dx

Private
ParisHealthcare & Life Scienceshttps://www.australdx.fr/

Last Round

Seed

Jul 24, 2025

Est. Valuation

$7.37M

Total Funding Raised

$4.74M

Company Overview

AUSTRAL Dx is a diagnostic equipment company that develops a device utilizing non-invasive, airborne ultrasound analysis to screen, diagnose, and monitor cardiac and pulmonary conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Medical AI, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

airborne ultrasoundmedical imagingcardiopulmonary diagnosispoint of care ultrasoundPOCUScontactless monitoringmedical AIAI diagnosticsclinical triageremote patient monitoringRPMemergency medicinedigital healthmedtechedge AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AUSTRAL Dx Comparables

Compare AUSTRAL Dx with similar companies based on industry and business-model similarity.

AUSTRAL Dx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acorai
78%
EchoNous
67%
Clarius Mobile Health
65%

AUSTRAL Dx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 24, 2025
CrowdfundingJun 2, 2025

AUSTRAL Dx Investors

Notable investors and investment history

AUSTRAL Dx investors
InvestorRounds
Kima VenturesCrowdfunding, Seed
Super CapitalSeed
Région Sud InvestissementSeed
Paris Business AngelsCrowdfunding, Seed
Angels SantéCrowdfunding, Seed
Better AngleCrowdfunding, Seed
iXcoreCrowdfunding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Grew 25% QoQ, from 12 to 15 employees.

  • Oct 16, 2025

    Grew 33% QoQ from 9 to 12 employees.

AUSTRAL Dx Filings

Explore SEC and related filing metadata, where available.

AUSTRAL Dx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AUSTRAL Dx's valuation, stock price, and market status.

Is AUSTRAL Dx a public or private company?

AUSTRAL Dx is a private company.

What is the current stock price of AUSTRAL Dx?

AUSTRAL Dx is a private company with no public stock price. No recent secondary market data is available.

How much is AUSTRAL Dx worth (valuation)?

AUSTRAL Dx's valuation is estimated at $7.4M based on funding round data.

Can I buy AUSTRAL Dx stock?

AUSTRAL Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AUSTRAL Dx's last funding round?

AUSTRAL Dx's most recent funding round was Seed on July 24, 2025.

Who are the main investors in AUSTRAL Dx?

Key investors in AUSTRAL Dx include Sorbonne Venture, Aloe Private Equity.

Will AUSTRAL Dx IPO soon?

No public IPO plans have been announced for AUSTRAL Dx.

How can I track AUSTRAL Dx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AUSTRAL Dx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range12
Year Founded2021
Last FundingJul 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?